Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active CompoundsReport as inadecuate




Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds - Download this document for free, or read online. Document in PDF available to download.

1

School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China

2

Department of Pharmacobiology and Therapeutics, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpakuku, Nagoya 468-8503, Japan





*

Author to whom correspondence should be addressed.



Academic Editor: Wenbin Deng

Abstract The pivotal role of cancer stem cells CSCs in the initiation and progression of malignancies has been rigorously validated, and the specific methods for identifying and isolating the CSCs from the parental cancer population have also been rapidly developed in recent years. This review aims to provide an overview of recent research progress of Chinese medicines CMs and their active compounds in inhibiting tumor progression by targeting CSCs. A great deal of CMs and their active compounds, such as Antrodia camphorate, berberine, resveratrol, and curcumin have been shown to regress CSCs, in terms of reversing drug resistance, inducing cell death and inhibiting cell proliferation as well as metastasis. Furthermore, one of the active compounds in coptis, berbamine may inhibit tumor progression by modulating microRNAs to regulate CSCs. The underlying molecular mechanisms and related signaling pathways involved in these processes were also discussed and concluded in this paper. Overall, the use of CMs and their active compounds may be a promising therapeutic strategy to eradicate cancer by targeting CSCs. However, further studies are needed to clarify the potential of clinical application of CMs and their active compounds as complementary and alternative therapy in this field. View Full-Text

Keywords: cancer stem cells; Chinese medicines; molecular targets cancer stem cells; Chinese medicines; molecular targets





Author: Ming Hong 1, Hor Yue Tan 1, Sha Li 1, Fan Cheung 1, Ning Wang 1, Tadashi Nagamatsu 2 and Yibin Feng 1,*

Source: http://mdpi.com/



DOWNLOAD PDF




Related documents